Camp Springs, MD, United States of America

Daniel W Zaharevitz


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 39(Granted Patents)


Company Filing History:

goldMedal1 out of 832,891 
Other
 patents

Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Daniel W. Zaharevitz

Introduction: Daniel W. Zaharevitz is an innovative inventor based in Camp Springs, MD. He has made significant contributions to the field of pharmaceutical development, particularly through his unique inventions in the area of cyclin-dependent kinase inhibitors. With a notable patent to his name, Zaharevitz exemplifies the spirit of creativity and problem-solving that defines successful innovators.

Latest Patents: Daniel W. Zaharevitz is credited with one patent titled "Fused azepinone cyclin dependent kinase inhibitors." This invention provides valuable insights into potential therapeutic applications and showcases Zaharevitz's dedication to advancing medical science.

Career Highlights: Throughout his career, Zaharevitz has focused on the development of novel therapeutic agents. His innovative work has positioned him as a prominent figure in his field, demonstrating a commitment to improving health outcomes through scientific research and invention.

Collaborations: Daniel W. Zaharevitz collaborates with talented individuals in the field, including colleagues Rick Gussio and Ravi Kumar Jalluri. These partnerships enhance the innovative process and contribute to the successful development of new inventions.

Conclusion: Daniel W. Zaharevitz is a noteworthy inventor whose work has the potential to impact the pharmaceutical industry significantly. With a focus on cutting-edge inventions and fruitful collaborations, he continues to push the boundaries of science and innovation. His contributions as an inventor not only reflect his expertise but also inspire future generations of innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…